Tower Research Capital (TRC)’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18K | Buy |
3,921
+2,573
| +191% | +$777 | ﹤0.01% | 4856 |
|
|
2025
Q1 | $1.31K | Sell |
1,348
-2,676
| -67% | -$2.61K | ﹤0.01% | 4740 |
|
|
2024
Q4 | $6.84K | Buy |
4,024
+2,213
| +122% | +$3.76K | ﹤0.01% | 4136 |
|
|
2024
Q3 | $5.14K | Sell |
1,811
-184
| -9% | -$523 | ﹤0.01% | 4322 |
|
|
2024
Q2 | $7.02K | Buy |
1,995
+1,374
| +221% | +$4.84K | ﹤0.01% | 4507 |
|
|
2024
Q1 | $3.67K | Buy |
621
+141
| +29% | +$833 | ﹤0.01% | 4822 |
|
|
2023
Q4 | $6.18K | Sell |
480
-474
| -50% | -$6.1K | ﹤0.01% | 4775 |
|
|
2023
Q3 | $6.12K | Sell |
954
-4
| -0.4% | -$26 | ﹤0.01% | 4642 |
|
|
2023
Q2 | $8.32K | Buy |
958
+136
| +17% | +$1.18K | ﹤0.01% | 4422 |
|
|
2023
Q1 | $12K | Buy |
822
+465
| +130% | +$6.79K | ﹤0.01% | 4097 |
|
|
2022
Q4 | $6K | Sell |
357
-294
| -45% | -$4.94K | ﹤0.01% | 4733 |
|
|
2022
Q3 | $10K | Buy |
651
+372
| +133% | +$5.71K | ﹤0.01% | 4546 |
|
|
2022
Q2 | $6K | Hold |
279
| – | – | ﹤0.01% | 4936 |
|
|
2022
Q1 | $7K | Buy |
+279
| New | +$7K | ﹤0.01% | 4737 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | – | – | 6381 |
|
|
2021
Q3 | $0 | Sell |
3
-165
| -98% | – | ﹤0.01% | 5998 |
|
|
2021
Q2 | $9K | Buy |
+168
| New | +$9K | ﹤0.01% | 4438 |
|
|
2021
Q1 | – | Sell |
-100
| Closed | -$7K | – | 5577 |
|
|
2020
Q4 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 4496 |
|
|
2019
Q4 | – | Sell |
-6
| Closed | -$1K | – | 4031 |
|
|
2019
Q3 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 3890 |
|
|
2017
Q2 | – | Sell |
-34
| Closed | -$4K | – | 3197 |
|
|
2017
Q1 | $4K | Buy |
34
+32
| +1,600% | +$3.77K | ﹤0.01% | 2324 |
|
|
2016
Q4 | $0 | Sell |
2
-8
| -80% | – | ﹤0.01% | 4177 |
|
|
2016
Q3 | $5K | Sell |
10
-5
| -33% | -$2.5K | ﹤0.01% | 2559 |
|
|
2016
Q2 | $9K | Buy |
+15
| New | +$9K | ﹤0.01% | 2924 |
|